Showing results (171-180 of 244) with videos related to
Sort By:
Pageof 25
Pediatric Rheumatology Online Journal|April 4, 2013
Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritisAnne Hinks, Paul Martin, Susan D Thompson, et al.The Lancet. Rheumatology|April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trialAthimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.Rheumatology (Oxford, England)|October 13, 2019
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world dataRebecca Davies, Diederik De Cock, Lianne Kearsley-Fleet, et al.Journal of Tropical Pediatrics|March 11, 2021
Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children's Hospital in IndiaAishwarya Venkataraman, S Balasubramanian, Sulochana Putilibai, et al.Pediatric Rheumatology Online Journal|December 6, 2018
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trialsFrances C Sherratt, Louise Roper, Simon R Stones, et al.Ocular Immunology and Inflammation|February 21, 2023
Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of UveitisG M Murray, N Griffith, P Sinnappurajar, et al.Pediatric Rheumatology Online Journal|June 11, 2020
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithmChandrika S Bhat, Mark Chopra, Savvas Andronikou, et al.The Lancet. Rheumatology|March 5, 2026
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumabAthimalaipet V Ramanan, Nicolino Ruperto, Ivan Foeldvari, et al.Cureus|May 25, 2026
Controlled Maxillofacial Administration of Levodopa in a Patient With Parkinson's Disease: A First-in-Human 24-Hour Follow-Up StudySuresh C Thirunavukarasu, B B V Ramanan, Devi Varadharaj, et al.Frontiers in Ophthalmology|July 10, 2024
Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseasesAlex Fonollosa, Ester Carreño, Antonio Vitale, et al.Pageof 25